Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Abramson Cancer Center at Penn Medicine
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
histologically or cytologically confirmed local advanced unresectable/metastatic adenocarcinoma of biliary tract
measurable disease
available tumor tissue for investigational immunohistochemical evaluations
ECOG PS 0-2
No prior chemotherapy, biologic therapy or radiation therapy
Age Eighteen and older
Lab values per protocol
You may not be if
Life expectancy less than three months
Concurrent use of chemotherapy not indicated in the study protocol or any other investigational agents and patients who have received investigational drugs less than four weeks prior to enrollment
Prior therapy, which affects or targets the EGF pathway
Treatment for other carcinomas within the last five years, except cured non-melanoma skin and treated in-situ cervical cancer
Recovery from major surgery within three weeks of the start of study treatment
